Cargando…

Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer

Gamma-synuclein (SNCG) is secreted from tumor cells and elevated in the urine of bladder cancer (BCa) patients, however, the diagnostic and prognostic values of urine SNCG for BCa remain unknown. Here, we used enzyme immunoassay and western blotting to measure urine SNCG levels. Patients with BCa or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Caiyun, Shi, Bingbing, Hao, Chonghua, Wang, Qinghai, Lv, Qiang, Xing, Nianzeng, Shou, Jianzhong, Qu, Like, Gao, Yanning, Qin, Chao, Zhao, Jiyu, Shou, Chengchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190035/ https://www.ncbi.nlm.nih.gov/pubmed/27223068 http://dx.doi.org/10.18632/oncotarget.9468

Ejemplares similares

Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion
por: Liu, Caiyun, et al.
Publicado: (2018)

Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen
por: Liu, Caiyun, et al.
Publicado: (2010)

Identification of γ-Synuclein as a Stage-Specific Marker in Bladder Cancer by Immunohistochemistry
por: Zhao, Jiyu, et al.
Publicado: (2014)

Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients
por: Min, Li, et al.
Publicado: (2016)

Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783
por: Tian, Wei, et al.
Publicado: (2012)

N-Terminal Polypeptide of Annexin A2 Decreases Infection of Mycoplasma hyorhinis to Gastric Cancer Cells
por: Yuan, Shiqin, et al.
Publicado: (2016)

Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration
por: Duan, Hongying, et al.
Publicado: (2014)

Anti-PAI-1 Monoclonal Antibody Inhibits the Metastasis and Growth of Esophageal Squamous Cell Carcinoma
por: Zheng, Yutian, et al.
Publicado: (2023)

Tumor Necrosis Factor-A Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis
por: Min, Li, et al.
Publicado: (2014)

Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway
por: Liu, Jiafei, et al.
Publicado: (2019)

PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer
por: Lian, Shenyi, et al.
Publicado: (2016)

Cancer and embryo expression protein 65 promotes cancer cell growth and metastasis
por: JIN, GENGLIN, et al.
Publicado: (2015)

Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion
por: Yang, Yongyong, et al.
Publicado: (2017)

Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells
por: Yang, Hua, et al.
Publicado: (2010)

Postoperative spindle cell nodule of the bladder: A case report and review of the literature
por: ZHAO, JIYU, et al.
Publicado: (2014)

PRL-3 promotes telomere deprotection and chromosomal instability
por: Lian, Shenyi, et al.
Publicado: (2017)

Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis
por: Zhao, Chuanke, et al.
Publicado: (2015)

Correction: Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
por: Chen, Shanmei, et al.
Publicado: (2022)

Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
por: Chen, Shanmei, et al.
Publicado: (2021)

Comparison of Laparoscopy and Open Radical Nephrectomy of Renal Cell Cancer
por: Wang, Dong, et al.
Publicado: (2019)

CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers
por: Chen, Huang, et al.
Publicado: (2021)

Integrated Analysis of Gene Expression Profiles Associated with Response of Platinum/Paclitaxel-Based Treatment in Epithelial Ovarian Cancer
por: Han, Yong, et al.
Publicado: (2012)

IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype
por: Yang, Feiya, et al.
Publicado: (2019)

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling
por: Peng, Lirong, et al.
Publicado: (2009)

Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis
por: Bai, Hongsong, et al.
Publicado: (2022)

Transcriptional Regulation of PES1 Expression by c-Jun in Colon Cancer
por: Xie, Wei, et al.
Publicado: (2012)

Sarsaparilla (Smilax Glabra Rhizome) Extract Inhibits Migration and Invasion of Cancer Cells by Suppressing TGF-β1 Pathway
por: She, Tiantian, et al.
Publicado: (2015)

Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy
por: Feng, Junnan, et al.
Publicado: (2018)

Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
por: Huang, Dongsheng, et al.
Publicado: (2016)

Knockdown of PRL-3 increases mitochondrial superoxide anion production through transcriptional regulation of RAP1
por: Yang, Yongyong, et al.
Publicado: (2018)

Gene regulatory pattern analysis reveals essential role of core transcriptional factors’ activation in triple-negative breast cancer
por: Min, Li, et al.
Publicado: (2017)

Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study
por: Guan, Youyan, et al.
Publicado: (2022)

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer
por: Cai, Zhao, et al.
Publicado: (2021)

Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma
por: Sun, Shuning, et al.
Publicado: (2023)

Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone
por: Liu, Fei, et al.
Publicado: (2022)

Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis
por: Cheng, Yidong, et al.
Publicado: (2015)

Sarcomatoid carcinoma of the renal pelvis: A case report
por: TIAN, XIQUAN, et al.
Publicado: (2014)

Exploring the Association between Urine Caffeine Metabolites and Urine Flow Rate: A Cross-Sectional Study
por: Wu, Shou En, et al.
Publicado: (2020)

The contemporary role and impact of urine-based biomarkers in bladder cancer
por: Duquesne, Igor, et al.
Publicado: (2017)

Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer
por: Elsharkawi, Fathia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_inp30531kkk8kag9n4grodv90l